1-3 of 3
Keywords: Paclitaxel
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Clinical Outcome of Paclitaxel and Carboplatin as Second-Line Chemotherapy for Advanced Urothelial Carcinoma Resistant to First-Line Therapy with Gemcitabine and Cisplatin

Available to Purchase
Subject Area:
Further Areas
Tomoaki Terakawa, Hideaki Miyake, Naoki Yokoyama, Akira Miyazaki, Hiroyuki Tanaka, Takaaki Inoue, Masato Fujisawa
Journal: Urologia Internationalis
Urol Int (2014) 92 (2): 180–185.
https://doi.org/10.1159/000354149
Published Online: 13 November 2013
...Tomoaki Terakawa; Hideaki Miyake; Naoki Yokoyama; Akira Miyazaki; Hiroyuki Tanaka; Takaaki Inoue; Masato Fujisawa Objective: The objective was to investigate the efficacy and tolerability of combined therapy with paclitaxel and carboplatin (TC) in patients with advanced urothelial carcinoma after...
View article titled, Clinical Outcome of Paclitaxel and Carboplatin as Second-Line Chemotherapy for Advanced Urothelial Carcinoma Resistant to First-Line Therapy with Gemcitabine and Cisplatin
Open the PDF for Clinical Outcome of Paclitaxel and Carboplatin as Second-Line Chemotherapy for Advanced Urothelial Carcinoma Resistant to First-Line Therapy with Gemcitabine and Cisplatin in another window
Journal Articles

Successful Management of Metastatic Urothelial Carcinoma with Gemcitabine and Paclitaxel Chemotherapy in a Hemodialysis Patient

Available to Purchase
Subject Area:
Further Areas
Hiroki Ide, Atsuko Satou, Katsura Hoshino, Yota Yasumizu, Yasumitsu Uchida, Yuji Tasaka, Takeshi Masuda
Journal: Urologia Internationalis
Urol Int (2011) 87 (2): 245–247.
https://doi.org/10.1159/000327511
Published Online: 28 June 2011
...Hiroki Ide; Atsuko Satou; Katsura Hoshino; Yota Yasumizu; Yasumitsu Uchida; Yuji Tasaka; Takeshi Masuda This is the first report of urothelial carcinoma (UC) in a hemodialysis (HD) patient treated with almost the same doses of gemcitabine and paclitaxel (GP) as those administered to patients...
View article titled, Successful Management of Metastatic Urothelial Carcinoma with Gemcitabine and Paclitaxel Chemotherapy in a Hemodialysis Patient
Open the PDF for Successful Management of Metastatic Urothelial Carcinoma with Gemcitabine and Paclitaxel Chemotherapy in a Hemodialysis Patient in another window
Journal Articles

Successful Treatment with Paclitaxel/Carboplatin Chemotherapy in Advanced Adenocarcinoma of the Urinary Tract Producing Carcinoembryonic Antigen, Carbohydrate Antigen 19-9 and Carbohydrate Antigen 125

Available to Purchase
Subject Area:
Further Areas
Manabu Kato, Takehisa Onishi, Akira Hoshina, Tadasihi Yabana
Journal: Urologia Internationalis
Urol Int (2010) 84 (1): 116–118.
https://doi.org/10.1159/000273479
Published Online: 17 February 2010
...) and carbohydrate antigen 125 (CA125), which were completely resected after induction chemotherapy with paclitaxel and carboplatin. Patient 1 was a 72-year-old woman with adenocarcinoma of the right renal pelvis and ureter. Patient 2 was a 73-year-old woman with adenocarcinoma of the bladder. Serum levels of CEA...
View article titled, Successful Treatment with Paclitaxel/Carboplatin Chemotherapy in Advanced Adenocarcinoma of the Urinary Tract Producing Carcinoembryonic Antigen, Carbohydrate Antigen 19-9 and Carbohydrate Antigen 125
Open the PDF for Successful Treatment with Paclitaxel/Carboplatin Chemotherapy in Advanced Adenocarcinoma of the Urinary Tract Producing Carcinoembryonic Antigen, Carbohydrate Antigen 19-9 and Carbohydrate Antigen 125 in another window